Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

mHealth Market by Devices (Blood Glucose Meters, BP Monitors, Pulse oximetry, Neurological Monitoring, Wearable fitness sensor device and Heart Rate Meters), Services (Diagnosis, Monitoring, Prevention, Treatment, Wellness and healthcare system) and Application (Cardiovascular, Diabetes, Respiratory, Neurological) - Global Opportunity Analysis and Industry Forecast, 2014 - 2020

LI_1577

Pages: 157

Formats:

May 2015 | 17767 Views

Charts: 42

Tables: 83

Author(s): James Franco

Purchase Option


mHealth Market Overview:

Global mHealth Market was valued at $10.5 billion in 2014 and is expected to grow at a CAGR of 33.5% during 2015-2020. The mHealth market is in its nascent stage and is expected to yield significant revenues with increasing awareness and favorable regulatory impositions specific to the quality and feasibility of mobile-based medical devices. Penetration of mobile phones in healthcare segment has had a significant impact on the overall healthcare industry.

Currently mobile penetration is more than 100% in developed markets and is expected to increase in developing markets such as Asia-Pacific, Latin America and Africa. Additionally, increasing exposure to smartphones along with 3G and 4G networks will further increase the use of mobile platforms in most of the sectors, especially in the healthcare systems. 

Some of the other factors responsible for substantial market growth include low cost and convenience of medical devices, technological innovations, integration of wireless technologies, and affordability of smartphones, government initiatives and increasing lifestyle diseases. Factors such as lower adoption due to lower accuracy, nascent technology in underdeveloped economies, limited reimbursement coverage, lack of technological awareness among the ageing population and uncertainty in government regulations are restricting market growth to a certain extent. 

The growth of mHealth device market is mainly attributed to the high revenue generated from blood glucose meters, cardiac monitors and BP monitors, which collectively accounted for 5/7th of the global mHealth devices revenue in 2015. This is attributed to the growing number of cardiac and BP disorders. BP monitors is the highest revenue generating segment in global mHealth devices market, whereas, blood glucose monitor is the fastest growing segment. Cardiac monitors market is the third largest segment growing with a CAGR of 37.5% during the forecast period. 

Global mHealth services market consists of diagnostic services, monitoring services, treatment, prevention and wellness & healthcare system strengthening solutions. The global mHealth service market is projected to grow at a CAGR of 32.2% during the analysis period. The growth of mHealth services market is attributed to rising revenues generated from monitoring services market. The rising adoption of monitoring services for chronic disease management, post-acute care management as well as aging population are supporting the monitoring services market growth. Going forward, diagnosis services and wellness & healthcare system strengthening solution collectively accounted for about 48% of global mHealth services market. The growth of these segments is attributed to the increased awareness about fitness & general wellness, growing government initiatives and rise in physician’s acceptance. Geographically, North America is expected to be the largest revenue-generating region for monitoring services market followed by Europe and Asia Pacific. Monitoring services are largely adopted in developed regions such as North America and Europe; however, Asia Pacific will generate significant level of revenue by 2020. This is mainly due to the increase in awareness of diseases and higher penetration of mobile platform in Asia Pacific region. 

mHealth stakeholders market consist of mobile operator, healthcare providers, application/content players and device vendors. Mobile operators are the most crucial players in the overall mHealth stakeholders market. North America is expected to be the largest revenue-generating region, mainly due to well-penetrated healthcare system. 

Global mHealth market further segmented into applications, which consists of cardiovascular disease, diabetes, respiratory diseases, neurological diseases and others. Cardiovascular segment was the largest revenue-generating segment, whereas, Diabetes, is the fastest growing segments registering a CAGR of 35.4% during the forecast period.

Value chain of global mHealth market

Get more information on this report : Request Sample Pages

New product launches and industry collaborations are some of the principal growth strategies adopted by marketers. The current product launches focus on basic cardiology and blood glucose monitors. Moreover, Smartwatches, Health monitors, Pedometers and Activity trackers are some of the trendy wearable devices launched by several companies such as Philips Healthcare, iHealth, LifeWatch AG, Apple, Samsung, etc. in mHealth market. Key players in the market are collaborating with service providers to retain their hold in the global mHealth market. One of the key players operating within the market, LifeWatch collaborated with China telecom for sales of medical smartphones. Key players included in the report are AT&T Inc., LifeWatch AG, Boston Scientific, Omron Healthcare, Philips Healthcare, Sanofi, Bayer Healthcare, Johnson & Johnson and Masimo Corporation.

Get more information on this report : Request Sample Pages

India Market Review:

The increased burden of non-communicable disease in India has exacerbated healthcare problems in India. Chronic diseases are the leading cause of death and disabilities. Moreover, India has the second highest prevalence of diabetes in the world after China with more than 61 million diabetes patients. It has been estimated that diabetes population would exceed about 100 million by 2030. This issue can be significantly addressed by the mHealth services, which would ultimately drive the market growth. On contrary, the poor network coverage, security and privacy of healthcare information are some of the factors limiting the growth of mHealth market in India.

Get more information on this report : Request Sample Pages

mHealth Market Key Benefits

  • The report covers a quantitative analysis of the current market scenario, size and estimations through 2014-2020 for mobile health market. The data would enable the stakeholders to capitalize on prevailing market opportunities as a result of health information systems.
  • The mobile health  market scenario is comprehensively analyzed based on key regions 
  • The report profiles the prominent market players and highlights their key strategies to stay ahead in the mHealth industry which helps in understanding the competitive outlook of the market. 
  • Extensive analysis of the mobile health  market size  is conducted by closely following key product positioning and monitoring the top contenders within the market framework
  • Comprehensive analysis of factors that drive and restrict the growth of the m-health market is provided in the report
  • Exhaustive analysis of the mHealth industry, by device type, helps in understanding the types of devices that are presently used, along with the variants that would gain prominence in future

mHealth Market Key Segments

By Devices

  • Blood glucose meters

  • BP monitors

  • Pulse oximetry

  • Neurological monitoring devices

  • Apnea and sleep monitors

  • Wearable fitness sensor device & heart rate meters 

  • Others

By Services

  • Diagnosis services

  • Monitoring services

  • Prevention

  • Treatment

  • Wellness and healthcare system strengthening solutions

By Stakeholders

  • Mobile operators

  • Device vendors

  • Healthcare providers

  • Application players

By Application

  • Cardiovascular diseases

  • Diabetes

  • Respiratory diseases

  • Neurological diseases

  • Others

By Geography

  • North America

    • US

    • Canada

    • Mexico

  • Europe

    • Germany

    • France 

    • United Kingdom

    • Italy

    • Russia

    • Rest of Europe

  • Asia-Pacific

    • Australia

    • Japan

    • China

    • India

    • Rest of Asia-pacific

  • LAMEA

    • Latin America

    • Middle East

    • Africa

CHAPTER 1 INTRODUCTION

1.1 Report Description
1.2 Key Benefits
1.3 Key Market Segments
1.4 Research Methodology

1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Analyst Tools and Models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO Prospective

CHAPTER 3 MARKET OVERVIEW

3.1 Market Definition and Scope
3.2 Key Findings

3.2.1 Top Factors Impacting Global mHealth Market
3.2.2 Top Investment Pockets- Global mHealth Market
3.2.3 Top Winning Strategies in Global mHealth Market

3.3 Porters Five Forces Analysis

3.3.1 Bargaining Power of Buyers
3.3.2 Bargaining Power of Suppliers
3.3.3 Threat of New Entrants
3.3.4 Threat of Substitute
3.3.5 Intense Competitive Rivalry

3.4 Value Chain Analysis

3.4.1 Primary Activities
3.4.2 Secondary Activities

3.5 Regulatory Issues, Legislations and Authorities

3.5.1 Regulations and Directives pertaining to mHealth in the U.S.
3.5.2 Regulations and directives Pertaining to mHealth in EU

3.6 Insurance Reimbursement Scenario
3.7 Market Player Positioning 2014
3.8 Clinical Trials (2011-2015)
3.9 Market Dynamics

3.9.1 Drivers

3.9.1.1 Integration of wireless technologies with portable healthcare devices
3.9.1.2 Increase in incidences of lifestyle disease
3.9.1.3 Cost and Convenience Factors
3.9.1.4 Technological innovations
3.9.1.5 Government initiative
3.9.1.6 Affordability of smartphones

3.9.2 Restrains

3.9.2.1 Lower adoption accross developing economies
3.9.2.2 Weak reimbursement coverage
3.9.2.3 Technological awareness among the ageing population
3.9.2.4 Uncertainty in the government regulations is expected to hinder the growth rate

3.9.3 Opportunities

3.9.3.1 Untapped market of developing economies
3.9.3.2 Rising Opportunities in the form of bundled services

CHAPTER 4 GLOBAL MHEALTH MARKET, BY DEVICES, 2014-2020

4.1 Blood Glucose Meter

4.1.1 Key Market Trends
4.1.2 Key Growth Factors and Opportunity
4.1.3 Market Size and Forecast

4.2 BP Monitors

4.2.1 Key Market Trends
4.2.2 Key Growth Factors and Opportunity
4.2.3 Market Size and Forecast

4.3 Pulse Oximetry

4.3.1 Key Market Trends
4.3.2 Key Growth Factors and Opportunity
4.3.3 Market Size and Forecast

4.4 Neurological Monitoring

4.4.1 Key Market Trends
4.4.2 Key Growth Factors and Opportunity
4.4.3 Market Size and Forecast

4.5 Cardiac Monitors

4.5.1 Key Market Trends
4.5.2 Key Growth Factors and Opportunity
4.5.3 Market Size and Forecast

4.6 Apnea and Sleep Monitors

4.6.1 Key Market Trends
4.6.2 Key Growth Factors and Opportunity
4.6.3 Market Size and Forecast

4.7 Wearable Fitness Sensor Device and Heart Rate Meters

4.7.1 Key Market Trends
4.7.2 Key  Growth Factors and Opportunity
4.7.3 Market Size and Forecast

4.8 Others

4.8.1 Market Size and Forecast

CHAPTER 5 GLOBAL MHEALTH MARKET, BY SERVICES, 2014-2020

5.1 Prevention

5.1.1 Market Size and Forecast

5.2 Diagnostic Services

5.2.1 Market Size and Forecast

5.3 Monitoring Services

5.3.1 Market Size and Forecast

5.4 Treatment

5.4.1 Market Size and Forecast

5.5 Wellness and Healthcare System Strengthening Solutions

5.5.1 Market Size and Forecast

CHAPTER 6 GLOBAL MHEALTH MARKET, BY STAKEHOLDERS, 2014-2020

6.1 Mobile Operators

6.1.1 Market Size and Forecast

6.2 Device Vendors

6.2.1 Market Size and Forecast

6.3 Healthcare Providers

6.3.1 Market Size and Forecast

6.4 Application/ Content Players

6.4.1 Market Size and Forecast

CHAPTER 7 GLOBAL MHEALTH MARKET, BY APPLICATION, 2014-2020

7.1 Cardiovascular

7.1.1 Market Size and Forecast

7.2 Diabetes

7.2.1 Market Size and Forecast

7.3 Respiratory

7.3.1 Market Size and Forecast

7.4 Neurology

7.4.1 Market Size and Forecast

7.5 Others

7.5.1 Market Size and Forecast

CHAPTER 8 GLOBAL MHEALTH MARKET, BY GEOGRAPHY, 2014-2020

8.1 North America

8.1.1 Key Market Trends
8.1.2 Key Growth Factors and Opportunity
8.1.3 Market Size and Forecast
8.1.4 United States

8.1.4.1 Market Size and Forecast

8.1.5 Canada

8.1.5.1 Market Size and Forecast

8.1.6 Mexico

8.1.6.1 Market Size and Forecast

8.2 Europe

8.2.1 Key Market Trends
8.2.2 Key Growth Factors and Opportunity
8.2.3 Market Size and Forecast
8.2.4 France

8.2.4.1 Market Size and Forecast

8.2.5 Germany

8.2.5.1 Market Size and Forecast

8.2.6 United Kingdom

8.2.6.1 Market Size and Forecast

8.2.7 Italy

8.2.7.1 Market Size and Forecast

8.2.8 Russia

8.2.8.1 Market Size and Forecast

8.2.9 Rest of Europe

8.2.9.1 Market Size and Forecast

8.3 Asia-Pacific

8.3.1 Key Market Trends
8.3.2 Key Growth Factors and Opportunity
8.3.3 Market Size and Forecast
8.3.4 Australia

8.3.4.1 Market Size and Forecast

8.3.5 China

8.3.5.1 Market Size and Forecast

8.3.6 Japan

8.3.6.1 Market Size and Forecast

8.3.7 India

8.3.7.1 Market Size and Forecast

8.3.8 Rest of Asia-pacific

8.3.8.1 Market Size and Forecast

8.4 LAMEA

8.4.1 Key Market Trends
8.4.2 Key Growth Factors and Opportunity
8.4.3 Market Size and Forecast
8.4.4 Latin America

8.4.4.1 Market Size and Forecast

8.4.5 Middle East

8.4.5.1 Market Size and Forecast

8.4.6 Africa

8.4.6.1 Market Size and Forecast

CHAPTER 9 COMPANY PROFILS

9.1 LifeWatch AG

9.1.1 Company Overview
9.1.2 LifeWatch AG Snapshot
9.1.3 Operating Business Segment Overview
9.1.4 Business Performance
9.1.5 Strategic Moves and Development
9.1.6 SWOT Analysis of LifeWatch AG

9.2 Masimo Corporation

9.2.1 Company Overview
9.2.2 Masimo Corporation snapshot
9.2.3 Operating Business Segment Overview
9.2.4 Business Performance
9.2.5 Strategic Moves and Developments
9.2.6 SWOT Analysis of Masimo Corporation

9.3 Omron healthcare

9.3.1 Company Overview
9.3.2 Omron Healthcare Snapshot
9.3.3 Operating Business Segment Overview
9.3.4 Business Performance
9.3.5 Strategic Moves and Developments
9.3.6 SWOT Analysis of Omron Healthcare Inc.

9.4 Philips healthcare (a division of Royal Philips company)

9.4.1 Company Overview
9.4.2 Philips Healthcare Snapshot
9.4.3 Operating Business Segment Overview
9.4.4 Business Performance
9.4.5 Strategic Moves and Developments
9.4.6 SWOT analysis of Philips Healthcare

9.5 Bayer Healthcare (a division of Bayer)

9.5.1 Company Overview
9.5.2 Bayer Healthcare snapshot
9.5.3 Operating Business Segment Overview
9.5.4 Business Performance
9.5.5 Strategic Moves and Development
9.5.6 SWOT Analysis Of Bayer Healthcare

9.6 Sanofi

9.6.1 Company Overview
9.6.2 Sanofi snapshot
9.6.3 Operating Business Segment Overview
9.6.4 Business Performance
9.6.5 Strategic Moves and Developments
9.6.6 SWOT analysis of Sanofi

9.7 Boston Scientific Corporation

9.7.1 Company Overview
9.7.2 Boston Scientific Corporation snapshot
9.7.3 Operating Business Segment
9.7.4 Business Performance
9.7.5 Strategic Moves and Developments
9.7.6 SWOT analysis of Boston Scientific Corporation

9.8 AT&T Inc.

9.8.1 Company Overview
9.8.2 AT&T Inc. snapshot
9.8.3 Operating business segment
9.8.4 Business Performance
9.8.5 Strategic Moves and Developments
9.8.6 SWOT analysis of AT&T Inc.

9.9 Johnson & Johnson

9.9.1 Company Overview
9.9.2 Johnson & Johnson Inc snapshot
9.9.3 Operating Business Segment Overview
9.9.4 Business Performance
9.9.5 Strategic Moves and Developments
9.9.6 SWOT analysis of Johnson & Johnson

LIST OF FIGURES

FIG. 1    TOP FACTORS IMPACTING GLOBAL MHEALTH MARKET 2014-2020
FIG. 2    TOP INVESTMENT POCKETS IN GLOBAL MHEALTH MARKET (2014-2020)
FIG. 3    TOP WINNING STRATEGIES IN GLOBAL MHEALTH MARKET (2012-2015)
FIG. 4    PORTER’S FIVE FORCES ANALYSIS
FIG. 5    VALUE CHAIN ANALYSIS OF GLOBAL MHEALTH MARKET
FIG. 6    MARKET PLAYER POSITIONING 2014
FIG. 7    GLOBAL PER CAPITA SMARTPHONE PENETRATION (2011-2018)
FIG. 8    ESTIMATED DEATH DUE TO CVDS (MILLION)
FIG. 9    PENETRATION OF SMARTPHONE USERS BY APPLICATIONS
FIG. 10    MHEALTH INITIATIVE BY WORLD HEALTH ORGANIZATION
FIG. 11    SMARTPHONE OWNERSHIP IN UNITED STATES (2011-2014)
FIG. 12    HEART RATE MONITORS
FIG. 13    FORCAST OF MORTALITY INCIDENCES FROM CVD
FIG. 14    ASTHMA PREVALENCE IN UNITED STATES IN 2011
FIG. 15    CANADIAN’S OPINION ABOUT HEALTHCARE SYSTEM
FIG. 16    BUSINESS PERFORMANCE OF LIFEWATCH 2012-2014 ($MILLION)
FIG. 17    REVENUE BY REGION (2014)
FIG. 18    SWOT ANALYSIS OF LIFEWATCH AG
FIG. 19    BUSINESS PERFORMANCE OF MASIMO CORPORATION 2012-2014 ($MILLION)
FIG. 20    SWOT ANALYSIS OF MASIMO CORPORATION
FIG. 21    NET SALES OF OMRON ($MILLION)
FIG. 22    OMRON’S NET SALES BY OPERATING SEGMENT (2013)
FIG. 23    OMRON’S NET SALES BY REGION (2013)
FIG. 24    SWOT ANALYSIS OF OMRON HEALTHCARE INC.
FIG. 25    PHILIPS NET SALES 2012-2014 ($MILLION)
FIG. 26    PHILIPS HEALTHCARE REVENUE BY OPERATING SEGMENT (2014)
FIG. 27    SWOT ANALYSIS OF PHILIPS HEALTHCARE
FIG. 28    NET SALES OF BAYER HEALTHCARE 2012-2014 ($MILLION)
FIG. 29    BAYER HEALTHCARE’S REVENUE BY OPERATING SEGMENT IN 2014
FIG. 30    SWOT ANALYSIS OF BAYER HEALTHCARE
FIG. 31    NET SALES OF SANOFI 2012-2014 ($MILLION)
FIG. 32    NET SALES OF SANOFI BY OPERATING SEGMENT (2014)
FIG. 33    NET SALES OF SANOFI BY GEOGRAPHY 2014
FIG. 34    SWOT ANALYSIS OF SANOFI
FIG. 35    OPERATIONAL SALES OF BOSTON SCIENTIFIC 2012-2014 ($MILLION)
FIG. 36    OPERATIONAL SALES BY OPERATING SEGMENT 2014
FIG. 37    SWOT ANALYSIS OF BOSTON SCIENTIFIC CORPORATION
FIG. 38    REVENUE OF AT&T INC. 2012-2014 ($MILLION)
FIG. 39    SWOT ANALYSIS OF AT&T INC.
FIG. 40    NET SALES OF JOHNSON & JOHNSON 2012-2014 ($MILLION)
FIG. 41    NET SALES BY OPERATING SEGMENT 2014
FIG. 42    SWOT ANALYSIS OF JOHNSON & JOHNSON.

LIST OF TABLES

TABLE 1 GLOBAL MHEALTH MARKET BY GEOGRAPHY, MODERATE GROWTH SCENARIO, 2020-2025, ($MILLION)
TABLE 2 GLOBAL MHEALTH MARKET BY GEOGRAPHY, RAPID GROWTH SCENARIO, 2020-2025, ($MILLION)
TABLE 3 GLOBAL MHEALTH MARKET BY GEOGRAPHY, CRITICAL GROWTH SCENARIO, 2020-2025, ($MILLION)
TABLE 4 CLINICAL TRIALS 2011-2015
TABLE 5 PATENT ANALYSIS- UNITED STATES (2011-2014)
TABLE 6 PATENT ANALYSIS- EUROPE (2011-2014)
TABLE 7 PATENT ANALYSIS- JAPAN (2011-2014)
TABLE 8 GLOBAL MHEALTH MARKET, BY DEVICES, 2014-2020 ($MILLION)
TABLE 9 DIABETES RELATED SMART PHONE APPLICATIONS
TABLE 10 GLOBAL MHEALTH BLOOD GLUCOSE METERS MARKET, BY GEOGRAPHY, 2014-2020($MILLION)
TABLE 11 MOBILE COMPATIBLE BP MONITORS
TABLE 12 GLOBAL MHEALTH BP MONITORS MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 13 AVAILABLE PULSE OXIMETERS AND ITS COST
TABLE 14 GLOBAL MHEALTH PULSE OXIMETERY MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 15 GLOBAL MHEALTH NEUROLOGICAL MONITORS MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 16 GLOBAL MHEALTH CARDIAC MONITORS MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 17 SLEEP AND APNEA DEVICES
TABLE 18 GLOBAL MHEALTH APNEA & SLEEP MONITORS MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 19 WEARABLE FITNESS DEVICES AND ITS COST
TABLE 20 GLOBAL MHEALTH WEARABLE FITNESS SENSOR DEVICES AND HEART RATE METERS MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 21 GLOBAL MHEALTH OTHER DEVICES MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 22 GLOBAL M-HEALTH SERVICES MARKET, BY TYPE, 2014-2020 ($MILLION)
TABLE 23 GLOBAL M-HEALTH SERVICES MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 24 SMARTPHONE APPS FOR PREVENTIVE SERVICES
TABLE 25 MOBILE HEALTHCARE SOLUTION PROVIDED BY CDAC
TABLE 26 GLOBAL MHEALTH PREVENTION SERVICE MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 27 GLOBAL MHEALTH DIAGNOSIS SERVICE MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 28 GLOBAL MHEALTH MONITORING SERVICE MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 29 GLOBAL MHEALTH TREATMENT SERVICE MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 30 GLOBAL MHEALTH WELLNESS AND HEALTHCARE SYSTEMS STRENGTHENING SOLUTIONS MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 31 GLOBAL MHEALTH MARKET, BY STAKEHOLDERS,2014-2020 ($MILLION)
TABLE 32 GLOBAL MHEALTH STAKEHOLDERS MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 33 GLOBAL MHEALTH MOBILE OPERATORS MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 34 GLOBAL MHEALTH DEVICE VENDORS MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 35 GLOBAL MHEALTH HEALTHCARE PROVIDERS MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 36 GLOBAL MHEALTH APPLICATION/CONTENT PLAYERS MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 37 GLOBAL MHEALTH MARKET BY APPLICATION, 2014-2020 ($MILLION)
TABLE 38 GLOBAL MHEALTH APPLICATION MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 39 GLOBAL MHEALTH CARDIOVASCULAR APPLICATION MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 40 PREVALENCE AND PROJECTIONS (DIABETES)
TABLE 41 GLOBAL MHEALTH DIABETES APPLICATION MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 42 GLOBAL MHEALTH RESPIRATORY APPLICATION MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 43 GLOBAL NUMBER OF DALYS FOR NEUROLOGICAL DISORDERS PROJECTION FOR 2015 AND 2030
TABLE 44 GLOBAL MHEALTH NEUROLOGY APPLICATION MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 45 IMPACT ANALYSIS PENETRATING TO GEOGRAPHY 2014
TABLE 46 NORTH AMERICA MHEALTH DEVICES MARKET BY COUNTRY, 2014-2020 ($MILLION)
TABLE 47 UNITED STATES MHEALTH MARKET (DEVICES AND SERVICES), 2014-2020, ($MILLION)
TABLE 48 CANADA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 49 EUROPE MHEALTH DEVICES MARKET, BY COUNTRY 2014-2020, ($MILLION)
TABLE 50 EUROPE MHEALTH SERVICES MARKET, BY COUNTRY 2014-2020, ($MILLION)
TABLE 51 FRANCE MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 52 GERMANY MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 53 UNITED KINGDOM (DEVICES AND SERVICES) MHEALTH MARKET, 2014-2020, ($MILLION)
TABLE 54 ITALY MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 55 RUSSIA MHEALTH (DEVICES AND SERVICES)MARKET, 2014-2020, ($MILLION)
TABLE 56 REST OF EUROPE MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 57 ASIA-PACIFIC MHEALTH DEVICES MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 58 ASIA-PACIFIC MHEALTH SERVICES MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 59 AUSTRALIA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 60 CHINA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 61 JAPAN MHEALTH (DEVICES AND SERVICES)MARKET, 2014-2020, ($MILLION)
TABLE 62 INDIA MHEALTH (DEVICES AND SERVICES)MARKET, 2014-2020, ($MILLION)
TABLE 63 REST OF ASIA-PACIFIC MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 64 LAMEA MHEALTH DEVICES MARKET, BY COUNTRY 2014-2020, ($MILLION)
TABLE 65 LAMEA MHEALTH SERVICES MARKET, BY COUNTRY 2014-2020, ($MILLION)
TABLE 66 LATIN AMERICA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 67 MIDDLE EAST MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 68 AFRICA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 69 LIFEWATCH AG COMPANY SNAPSHOT
TABLE 70 MASIMO CORPORATION SNAPSHOT
TABLE 71 OPERATING SEGMENT
TABLE 72 OMRON HEALTHCARE SNAPSHOT
TABLE 73 OPERATING BUSINESS SEGMENT OVERVIEW
TABLE 74 PHILIPS HEALTHCARE SNAPSHOT
TABLE 75 OPERATING BUSINESS SEGMENT OVERVIEW
TABLE 76 BAYER HEALTHCARE SNAPSHOT
TABLE 77 OPERATING BUSINESS SEGMENT OVERVIEW
TABLE 78 SANOFI SNAPSHOT OF SANOFI
TABLE 79 OPERATING BUSINESS SEGMENTS OVERVIEW
TABLE 80 BOSTON SCIENTIFIC CORPORATION SNAPSHOT
TABLE 81 OPERATING BUSINESS SEGMENT
TABLE 82 AT&T INC. SNAPSHOT
TABLE 83 OPERATING BUSIMESS SEGMENT
TABLE 84 JOHNSON & JOHNSON INC. COMPANY SNAPSHOT
TABLE 85 OPERATING BUSINESS

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Have a question ?

Need to add more ?

Featured Readings

Get Fresh Content Delivered

Get insights on topics that matter to your business. Stay updated on the areas that interest you.

Get Industry Data Alerts >